Total planned funding: $255,250,897
Allocations
Countries/Regions
| Eswatini | $255,250,897 |
Organizational Types
| Private Contractor | $58,620,665 |
| NGO | $51,357,396 |
| Unknown | $49,954,017 |
| University | $45,534,005 |
| Own Agency | $29,870,462 |
| Host Country Government Agency | $9,002,499 |
| FBO | $5,360,534 |
| Other USG Agency | $3,177,479 |
| Multi-lateral Agency | $1,783,840 |
| Implementing Agency | $590,000 |
Program Areas
| Care | $68,413,139 |
| Treatment | $65,391,861 |
| Prevention | $54,845,433 |
| Governance and Systems | $30,618,800 |
| Management and Operations | $20,990,186 |
| Testing | $14,991,478 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $55,507,159 |
| HBHC: Care: Adult Care and Support | $26,667,661 |
| HKID: Care: Orphans and Vulnerable Children | $23,961,515 |
| HVMS: Management and Operations | $20,990,186 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $18,499,236 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,143,242 |
| HVCT: Testing: HIV Testing and Counseling | $14,991,478 |
| HVSI: Strategic Information | $13,160,078 |
| HVTB: Care: TB/HIV | $12,207,878 |
| OHSS: Health Systems Strengthening | $11,650,954 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,764,681 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,698,274 |
| PDTX: Treatment: Pediatric Treatment | $6,131,156 |
| HLAB: Laboratory Infrastructure | $5,807,768 |
| PDCS: Care: Pediatric Care and Support | $5,576,085 |
| HTXD: Treatment: ARV Drugs | $3,753,546 |
| HMBL: Biomedical Prevention: Blood Safety | $740,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$40,662,773
Countries/Regions
Not Available:
$35,390,150
Countries/Regions
Pact, Inc.:
$31,517,233
Countries/Regions
USG Aggregated Agencies:
$14,983,192
Countries/Regions